vesiclemembraneproteinassoci
protein
vapa
oxysterolbind
protein
osbp
regul
intracellular
cholesterol
homeostasi
requir
mani
viru
infect
entri
virus
viruscontain
vesicl
fuse
endosom
membran
mediat
cytosol
releas
virion
alter
endosom
cholesterol
inhibit
invas
step
show
antivir
effector
protein
interferoninduc
transmembran
protein
interact
vapa
prevent
associ
osbp
therebi
disrupt
intracellular
cholesterol
homeostasi
inhibit
viral
entri
alter
vapaosbp
function
induc
mark
accumul
cholesterol
multivesicular
bodi
late
endosom
inhibit
fusion
intralumin
virioncontain
vesicl
endosom
membran
therebi
block
viru
releas
cytosol
consequ
ectop
express
deplet
vapa
gene
profoundli
affect
inhibit
viral
entri
thu
disrupt
intracellular
cholesterol
homeostasi
block
viral
entri
underscor
import
cholesterol
viru
infect
cellular
lipid
membran
form
barrier
tightli
regul
entri
egress
mani
virus
cholesterol
essenti
lipid
raft
membran
organ
section
within
plasma
membran
endosom
compart
organel
numer
studi
demonstr
lipid
raft
membran
cholesterol
play
vital
role
cellular
pathway
cell
biolog
phenomena
also
critic
function
viral
infect
es
et
al
schroeder
specif
membran
lipid
raft
involv
entri
assembl
bud
mani
nonenvelop
envelop
virus
influenza
viru
iav
vesicular
stomat
viru
vsv
human
immunodefici
epsteinbarr
viru
ebv
ebola
viru
marburg
viru
herp
simplex
viru
hsv
chang
et
al
gianni
campadellifium
veit
thaa
wang
et
al
intracellular
cholesterol
level
increas
endocytosi
extracellular
cholesterol
well
de
novo
biosynthesi
ikonen
ioannou
modul
intracellular
cholesterol
homeostasi
within
cell
especi
endosom
compart
dramat
effect
entri
stage
viral
infect
carett
et
al
danthi
chow
gruenberg
kobayashi
et
al
poh
et
al
chang
intracellular
cholesterol
homeostasi
cours
infect
therefor
either
part
cellular
reprogram
process
facilit
viral
replic
andor
specif
infectioninduc
host
defens
respons
thu
intracellular
cholesterol
homeostasi
may
potenti
target
disrupt
viruscontain
cargo
reveal
avenu
combat
viral
infect
normal
physiolog
condit
cholesterol
deliv
endosom
compart
subject
hydrolysi
transport
cytosol
addit
de
novo
synthes
cholesterol
anoth
sourc
cholesterol
cell
must
transport
endoplasm
reticulum
er
organel
endosom
lysosom
golgi
mitochondria
plasma
membran
holthui
levin
vesicleassoci
membran
protein
vamp
associ
protein
vapa
oxysterolbind
protein
osbp
two
import
protein
implic
process
raychaudhuri
prinz
specif
major
sperm
protein
msp
domain
vapa
interact
ffat
motif
osbp
transfer
cholesterol
er
organel
howev
detail
mechan
vapaosbp
complexmedi
cholesterol
transport
still
elus
holthui
levin
levin
hand
seen
niemannpick
type
diseas
disturb
cholesterol
transport
endosom
compart
cytosol
result
cholesterol
accumul
late
endosom
multivesicular
bodi
mvb
maxfield
taba
subramanian
balch
mani
virus
includ
iav
vsv
enter
cytoplasm
cross
endosom
compart
mvb
uchil
moth
cholesterol
accumul
late
endosom
mvb
impair
viral
function
prevent
deliveri
viral
capsid
genom
cytosol
chevalli
et
al
sobo
et
al
exampl
vsv
infect
fusion
viral
envelop
endosom
membran
nucleocapsid
releas
occur
sequenti
two
success
step
endocyt
pathway
initi
fusion
occur
transport
intermedi
earli
late
endosom
follow
backfus
intern
vesicl
limit
membran
late
endosom
second
step
depend
late
endosom
phospholipid
lipid
lysobisphosphatid
acid
lbpa
regul
signal
via
protein
kobayashi
et
al
le
blanc
et
al
hand
reli
cholesterolladen
lipid
raft
membran
microdomain
entri
egress
suscept
cell
specif
intact
intracellular
cholesterol
traffick
pathway
mediat
cholesterolshuttl
need
effici
releas
product
tang
et
al
furthermor
recent
studi
also
identifi
membran
fusion
mediat
filoviru
glycoprotein
viral
escap
vesicular
compart
requir
protein
carett
et
al
et
al
thu
integr
membran
lipid
raft
cholesterol
homeostasi
essenti
order
assembl
releas
number
differ
infecti
viru
particl
host
innat
immun
activ
upon
viral
entri
thu
act
first
line
defens
viral
infect
mainli
via
antivir
interferon
ifn
stimul
gene
isg
sadler
william
approxim
isg
gene
identifi
exact
molecular
mechan
mani
remain
elus
schoggin
et
al
yan
chen
recent
shown
ifninduc
transmembran
ifitm
protein
restrict
replic
multipl
virus
includ
iav
sar
coronaviru
filovirus
ebola
marburg
virus
flavivirus
dengu
west
nile
virus
vsv
bailey
et
al
brass
et
al
other
also
demonstr
ifitm
protein
restrict
lu
et
al
contrast
ifitm
inhibit
entri
process
amphotrop
mous
leukemia
viru
mlv
machupo
viru
mach
lassa
viru
lasa
lymphocyt
choriomening
viru
lcmv
diamond
farzan
ifitm
isoform
rel
small
amino
acid
share
common
topolog
two
conserv
transmembran
domain
short
highli
conserv
cytoplasm
region
lumin
aminoand
carboxyl
termini
siegrist
et
al
wee
et
al
recent
studi
show
spalmitoyl
ubiquitin
play
crucial
role
function
yount
et
al
yount
et
al
may
influenc
vatpas
complex
activ
facilit
subcellular
local
clathrin
wee
et
al
three
addit
studi
show
ntermin
amino
acid
residu
requir
antivir
activ
vsv
iav
everitt
et
al
jia
et
al
weidner
et
al
final
ifitmmedi
restrict
bypass
induc
viral
fusion
plasma
membran
suggest
site
mechan
viral
entri
affect
sensit
ifitmmedi
restrict
huang
et
al
despit
current
activ
investig
detail
mechan
ifitmmedi
antivir
activ
still
elus
studi
describ
mechan
ifitm
protein
exert
antivir
activ
found
interact
vapa
interact
antagon
vapaosbp
function
disturb
intracellular
cholesterol
homeostasi
result
cholesterolladen
late
endosom
compart
block
viral
releas
cytosol
contrast
vapa
express
facilit
fusion
intern
vesicl
limit
membran
endosom
allow
viral
releas
cytosol
ifitm
inhibit
vapaosbp
function
disturb
integr
cholesterol
homeostasi
therefor
block
viral
entri
repres
antivir
strategi
offer
target
therapeut
avenu
combat
viral
infect
identifi
mediat
antivir
activ
yeast
twohybrid
screen
assay
perform
fulllength
clone
vector
bait
yeast
express
transform
human
leukocyt
matchmak
complementari
dna
cdna
librari
screen
reveal
interact
fulllength
vapa
immunoprecipit
ip
assay
confirm
interact
endogen
vapa
cell
figur
interact
vapa
confirm
overexpress
condit
figur
identifi
domain
vapa
respons
ifitm
interact
vapa
ifitm
fragment
clone
activ
dna
bind
vector
respect
map
studi
reveal
ifitm
fragment
contain
transmembran
domain
alon
vapa
fragment
contain
coiledcoil
domain
ccd
transmembran
tm
domain
respons
interact
figur
figur
avail
onlin
pulldown
assay
mammalian
glutathion
stransferas
gst
ifitm
fusion
confirm
region
suffici
vapa
bind
figur
show
similar
bind
affin
vapa
appear
slightli
higher
bind
affin
vapa
vapb
figur
result
demonstr
specif
interact
ifitm
vapa
interact
vapa
osbp
play
import
role
transfer
cholesterol
er
organel
cholesterol
homeostasi
holthui
levin
levin
maxfield
taba
test
whether
osbp
affect
interact
vapa
osbp
vapa
respect
bacteri
purifi
gstvapa
fusion
protein
figur
mix
wholecel
lysat
contain
osbp
follow
gst
pulldown
gstpd
immunoblot
assay
experi
reveal
increas
interact
led
decreas
vapaosbp
interact
wherea
increment
osbp
affect
interact
figur
data
indic
block
interact
vapa
osbp
vapabind
depend
manner
previous
shown
inhibit
earli
stage
viral
entri
brass
et
al
feeley
et
al
assess
effect
interact
viral
infect
human
lung
epitheli
cell
express
vector
vapa
figur
infect
vsv
iav
strain
viral
replic
measur
use
standard
plaqu
assay
surprisingli
replic
vsv
iav
dramat
restrict
cell
slightli
elev
cell
compar
cell
figur
vapa
express
cell
effect
counteract
restrict
vsv
iav
replic
figur
confirm
effect
vapa
express
activ
endogen
vapa
express
cell
deplet
vapaspecif
short
hairpin
rna
shrna
figur
viral
replic
show
although
deplet
vapa
gene
express
appar
reduc
vsv
iav
replic
cell
effect
appar
cell
figur
singl
cycl
viral
entri
also
evalu
use
defect
pseudoretrovirus
carri
variou
viral
envelop
previous
shown
brass
et
al
effect
inhibit
entri
vsv
iav
iav
udorn
lymphocyt
choriomening
viru
lcmv
moloney
leukemia
viru
mlv
machupo
viru
mach
lassa
viru
lasa
figur
vapa
express
counteract
antivir
activ
result
detect
increas
vsv
iav
entri
wherea
vapa
deplet
consider
suppress
vsv
iav
entri
mocktransfect
well
e
variou
fragment
vapa
gene
fulllength
gene
use
assay
f
bacteri
purifi
gstvapa
protein
mix
osbpcontain
cell
lysat
increas
amount
cell
lysat
left
panel
bacteri
purifi
gstvapa
protein
mix
cell
lysat
increas
amount
osbpcontain
cell
lysat
right
panel
mixtur
incub
hr
c
follow
gst
pulldown
pd
ib
indic
antibodi
wcl
use
ib
indic
antibodi
see
also
figur
cell
figur
howev
neither
express
deplet
osbp
gene
show
detect
effect
vsv
entri
replic
figur
data
shown
result
collect
demonstr
restrict
viral
infect
depend
vapa
express
suggest
vapa
gene
play
import
role
viral
entri
antagon
activ
endosom
compart
detect
plasma
membran
figur
local
primarili
endosom
lysosom
compart
indic
coloc
endosom
lysosom
marker
figur
furthermor
mostli
coloc
though
weakli
viral
entri
express
mean
egfp
fluoresc
rel
vector
control
cell
measur
flow
cytometri
valu
repres
mean
sd
n
r
independ
experi
h
cell
line
infect
lentiviru
carri
either
vapashrna
vapash
scshrna
scsh
day
cell
incub
defect
mlvegfp
pseudotyp
envelop
protein
vsv
iav
iav
udorn
viral
entri
express
mean
egfp
fluoresc
rel
vector
control
cell
measur
flow
cytometri
valu
repres
mean
sd
n
r
independ
experi
see
also
figur
indic
late
endosom
local
figur
addit
exclud
cellular
compart
lipid
dropletcontain
vacuol
site
local
figur
confoc
microscopi
reveal
endogen
vapa
partial
coloc
enlarg
endosom
compart
cell
figur
data
demonstr
mainli
present
late
endosom
compart
partli
coloc
vapa
although
express
dramat
affect
biogenesi
endosom
compart
lead
morpholog
chang
endosom
compart
feeley
et
al
express
affect
endosom
protein
level
figur
ifitm
protein
block
interact
vapa
osbp
mediat
transfer
cholesterol
er
organel
ikonen
determin
intracellular
cholesterol
level
use
histochem
cholesterol
marker
filipin
nile
red
dye
endosom
compart
cell
show
much
higher
cholesterol
level
cell
figur
figur
top
panel
cholesterolladen
endosom
compart
also
b
togeth
antimyc
antibodi
scale
bar
mm
insert
right
panel
show
magnifi
imag
metric
valu
mean
sd
insert
repres
coloc
quantif
either
filipin
nile
red
calcul
pearson
correl
coeffici
base
cell
c
cell
stain
filipin
togeth
antimyc
antilbpa
antibodi
scale
bar
mm
coloc
lbpa
quantifi
pearson
coeffici
mean
sd
n
r
cell
stain
nile
red
dye
measur
intracellular
cholesterol
level
flow
cytometri
mean
fluoresc
intens
mfi
compar
present
rel
fold
compar
cell
posit
control
cell
treat
mgml
cholesterol
transport
inhibitor
induc
cholesterol
accumul
endosom
compart
valu
repres
mean
sd
n
independ
experi
signific
differ
p
valu
compar
mark
asterisk
e
cell
wash
time
pb
treat
differ
concentr
mm
mbcd
freeserum
media
c
min
cell
wash
three
time
incub
defect
mlvegfp
pseudotyp
vsvgp
viral
entri
express
mean
egfp
fluoresc
rel
cell
measur
flow
cytometri
valu
repres
mean
sd
n
r
independ
experi
f
infect
lentiviru
carri
vapashrna
scshrna
two
day
cell
fix
stain
nile
red
subject
flow
cytometri
analysi
measur
intracellular
cholesterol
level
see
also
figur
enrich
lysobisphosphatid
acid
lbpa
phospholipid
import
role
cholesterol
homeostasi
chevalli
et
al
kobayashi
et
al
figur
flow
cytometri
biochem
analys
show
intracellular
cholesterol
level
total
cholesterol
free
cholesterol
consider
increas
upon
express
wherea
appar
decreas
vapa
express
figur
furthermor
express
led
increas
endosom
cholesterol
level
seen
express
figur
cholesterolladen
endosom
compart
suppress
viral
releas
late
endosom
cytosol
inhibit
fusion
process
chevalli
et
al
le
blanc
et
al
cell
treat
cholesteroldeplet
agent
methylbcyclodextrin
mbcd
follow
nile
red
dye
stain
detect
intracellular
cholesterol
level
infect
defect
pseudoretrovirus
measur
vsv
entri
mbcd
treatment
cell
detect
reduc
endosom
cholesterol
level
increas
singlecycl
viral
entri
figur
furthermor
shrnamedi
deplet
vapa
express
also
increas
endosom
cholesterol
level
figur
correl
decreas
viral
entri
replic
figur
find
collect
indic
disturb
vapaosbp
interact
result
cholesterol
accumul
endosom
compart
ultim
inhibit
viral
entri
demonstr
specif
action
mutant
lack
ctermin
region
incap
interact
vapa
figur
test
abil
disturb
cholesterol
homeostasi
viral
entri
loss
vapa
interact
express
mutant
neither
led
accumul
endosom
cholesterol
block
gfpiav
gfpvsv
replic
figur
cell
also
incap
inhibit
viral
entri
challeng
singlecycl
infect
defect
pseudoretrovirus
carri
vsv
iav
iav
udorn
glycoprotein
figur
howev
mutant
appar
express
lower
level
compar
wildtyp
wt
present
throughout
cytoplasm
unlik
wt
figur
reason
region
thu
replac
transmembran
region
transferrin
receptor
tr
gener
chimera
respect
figur
wherea
mutant
chimera
coloc
similar
wt
neither
chimera
capabl
bind
vapa
figur
detect
effect
interact
vapa
osbp
figur
consequ
express
display
littl
effect
accumul
endosom
cholesterol
figur
replic
gfpiva
gfpvsv
figur
final
chimera
also
incap
inhibit
viral
entri
challeng
singlecycl
infect
defect
pseudoretrovirus
carri
vsv
iav
iva
udorn
glycoprotein
figur
result
collect
indic
vapa
interact
trigger
accumul
endosom
cholesterol
therebi
inhibit
viral
entri
confoc
microscopi
show
express
led
pronounc
enlarg
compart
costain
filipin
cholesterol
marker
figur
upper
panel
consist
transmiss
electron
microscopi
tem
immunogold
electron
microcopi
em
also
reveal
robustli
induc
multivesicular
bodi
mvb
format
primarili
present
abund
intralumin
vesicl
wherea
minor
popul
also
present
cell
surfac
figur
strikingli
confoc
microscopi
show
vapa
express
alter
enlarg
mvb
becom
ring
shape
structur
hardli
costain
filipin
figur
lower
panel
tem
immunogold
em
also
reveal
upon
vapa
express
cell
intralumin
vesicl
mvb
push
edg
appar
fuse
surround
limit
membran
figur
level
ring
form
structur
endosom
compart
cell
markedli
higher
cell
figur
note
immunogold
em
also
show
vapa
present
cytoplasm
er
endosom
compart
cell
line
figur
cell
show
normal
structur
morpholog
though
cell
exhibit
swollen
endoplasm
reticulum
alter
mvb
format
cell
line
figur
result
demonstr
express
robustli
induc
mvb
format
wherea
vapa
express
appear
trigger
fusion
intralumin
vesicl
limit
membran
mvb
shown
vsv
entri
viral
fusion
occur
abund
intern
vesicl
mvb
first
follow
backfus
intern
vesicl
limit
mvb
membran
ultim
lead
cytoplasm
deliveri
vsv
nucleocapsid
le
blanc
et
al
uchil
moth
shown
figur
inhibit
earli
stage
vsv
entri
inhibit
compromis
vapa
express
consist
tem
also
reveal
vsv
particl
extens
pack
within
mvb
cell
figur
figur
hand
limit
number
vsv
particl
observ
mvb
cell
intralumin
vesicl
mvb
appar
fuse
surround
limit
membran
figur
delin
vsv
entri
cell
immunolabel
nm
nanogoldconjug
antimyc
antibodi
detect
myctag
nm
nanogoldconjug
antivsvg
antibodi
detect
vsv
glycoprotein
immunogold
em
reveal
vsvg
protein
accumul
abund
intralumin
vesicl
mvb
cell
also
present
figur
strike
contrast
vsv
glycoprotein
locat
surround
limit
membran
mvb
cell
figur
result
demonstr
vsv
particl
accumul
intralumin
vesicl
mvb
express
cell
wherea
redistribut
near
surround
limit
membran
mvb
upon
vapa
express
suggest
compromis
vapa
function
disturb
endosom
cholesterol
level
block
fusion
intralumin
vesicl
limit
membran
mvb
therebi
inhibit
viral
releas
cytosol
ifitm
protein
famili
small
isg
possess
variou
function
includ
adhes
antiprolifer
apoptosi
develop
bone
miner
tumor
progress
siegrist
et
al
zhang
et
al
although
ifitm
protein
identifi
around
two
decad
ago
antivir
role
discov
recent
suggest
potenti
target
antivir
therapi
human
pathogen
virus
includ
iav
ebola
viru
dengu
viru
west
nile
viru
sar
coronaviru
despit
activ
investig
detail
ifitmmedi
antivir
mechan
elus
studi
report
interact
vapa
interact
antagon
vapaosbp
function
disturb
intracellular
cholesterol
homeostasi
result
cholesterolladen
mvb
late
endosom
therebi
block
viral
releas
cytosol
figur
vapa
vapb
type
ii
membran
protein
conserv
yeast
human
gener
local
er
subcellular
organel
lev
et
al
vapa
involv
vesicl
transport
membran
fusion
though
precis
detail
function
unclear
also
play
import
role
cholesterol
homeostasi
interact
cytosol
cholesterol
sensor
osbp
holthui
levin
maxfield
taba
raychaudhuri
prinz
vapa
compos
three
domain
major
sperm
protein
msp
domain
coiledcoil
domain
ccd
transmembran
tm
domain
base
previou
report
wyle
et
al
studi
ntermin
msp
domain
vapa
suffici
bind
osbp
wherea
central
ccd
ctermin
tm
vapa
respons
ifitm
interact
suggest
vapa
may
independ
interact
osbp
ifitm
yet
found
interact
effect
suppress
interact
vapa
osbp
hand
neither
osbp
express
osbp
deplet
effect
interact
antivir
activ
howev
result
may
conclus
least
differ
isoform
osbp
raychaudhuri
prinz
nevertheless
result
suggest
interact
may
consider
chang
vapa
structur
local
disrupt
osbp
bind
thu
disturb
intracellular
cholesterol
homeostasi
two
report
recent
shown
spalmitoyl
membraneproxim
cystein
residu
posit
impact
antivir
activ
yount
et
al
wherea
posttransl
ubiquitin
neg
effect
antivir
activ
yount
et
al
furthermor
base
posttransl
modif
studi
new
dualpass
transmembran
topolog
ifitm
n
terminu
c
terminu
ifitm
concurr
cytoplasm
yount
et
al
introduc
jia
colleagu
jia
et
al
also
shown
first
amino
acid
n
terminu
import
reloc
endosom
compart
lack
region
impair
function
specif
tyrosin
residu
ppni
motif
amino
acid
critic
function
although
other
diamond
farzan
show
ifitm
termini
exist
extracellularli
plasma
membran
new
anticip
ifitm
topolog
would
inconsist
propos
model
figur
interact
vapa
control
intracellular
cholesterol
level
shown
norwalk
viru
nonstructur
protein
interact
vapa
interact
affect
intracellular
traffick
pathway
ettayebi
hardi
addit
hepat
c
viru
hcv
shown
target
vap
osbp
regul
viral
replic
specif
protein
hcv
interact
vapa
vapb
isoform
interact
posit
affect
hcv
replic
gao
et
al
hamamoto
et
al
addit
ntermin
domain
hcv
protein
interact
osbp
import
hcv
particl
releas
amako
et
al
howev
none
studi
detail
interact
specif
affect
viral
replic
matur
cholesterol
essenti
molecul
life
cycl
hcv
target
vapa
osbp
may
play
signific
role
hcv
replic
pathogenesi
may
also
lead
evas
ifitmmedi
antivir
activ
studi
current
activ
investig
accumul
cholesterol
within
late
endosom
compart
shown
impair
function
significantli
impair
infect
certain
virus
enter
cell
endocytosi
iav
vsv
dengu
viru
lakadamyali
et
al
pattanakitsakul
et
al
show
express
induc
substanti
accumul
cholesterol
within
mvb
late
endosom
compart
vapabindingdepend
manner
also
reproduc
observ
transient
increas
cholesterol
accumul
endosom
well
pronounc
enlarg
cholesterolenrich
late
endosom
compart
upon
ifnb
treatment
data
shown
suggest
observ
express
physiolog
relev
howev
level
intracellular
cholesterol
accumul
induc
ifnb
treatment
weaker
induc
overexpress
may
ifnb
treatment
affect
express
gene
includ
gene
cholesterol
synthesi
cholesterol
efflux
furthermor
recent
paper
roth
whittak
report
endosomespecif
lbpa
select
increas
rate
vsv
gmediat
membran
fusion
rate
iav
hamedi
membran
fusion
hand
hamedi
membran
fusion
depend
dynam
molecular
shape
lipid
inhibit
invert
coneshap
lipid
lysophosphatidylcholin
promot
oleic
acid
chernomordik
et
al
contrast
show
increas
endosom
cholesterol
induc
ifitm
lead
effici
inhibit
vsv
iav
entri
suggest
lipid
moieti
may
differ
select
activ
regul
fusion
event
upon
viral
entri
region
delet
replac
tm
region
protein
vapa
interact
complet
lost
accordingli
cholesterol
accumul
figur
figur
interestingli
cell
show
similar
phenotyp
cell
deriv
diseas
autosom
disord
massiv
accumul
cholesterol
late
endosom
compart
peak
vanc
subramanian
balch
cell
challeng
variou
virus
also
show
defect
viral
infect
particularli
entri
step
gruenberg
kobayashi
et
al
le
blanc
et
al
furthermor
recent
studi
identifi
membran
fusion
mediat
filoviru
glycoprotein
viral
escap
vesicular
compart
requir
protein
specif
directli
bind
viral
glycoprotein
gp
ultim
facilit
membran
fusion
induc
viral
releas
cytosol
carett
et
al
et
al
sever
piec
evid
also
indic
member
rab
gtpase
famili
may
impair
cholesterol
accumul
thu
express
rab
gtpase
complement
defect
seen
cell
decreas
endosom
cholesterol
level
subsequ
allow
viral
infect
ganley
pfeffer
lebrand
et
al
narita
et
al
zhang
et
al
howev
express
gene
cell
neither
decreas
endosom
cholesterol
level
increas
vsv
iav
infect
juj
sabo
unpublish
data
contrast
vapa
express
reduc
endosom
cholesterol
level
ultim
enhanc
vsv
iav
infect
furthermor
accumul
cholesterol
late
endosom
npc
cell
cell
led
increas
size
compart
importantli
properti
dynam
intralumin
vesicl
late
endosom
show
reduc
back
fusion
limit
membran
block
vsv
releas
cytosol
sobo
et
al
suggest
patholog
accumul
cholesterol
induc
dramat
perturb
fusion
intralumin
vesicl
virioncontain
compart
limit
membran
mvb
ultim
block
viral
releas
cytosol
figur
also
indic
cell
phenocopi
cell
util
differ
mechan
induc
accumul
endosom
cholesterol
therebi
block
viral
entri
note
iav
vsv
use
classic
endocytosi
pathway
depend
caveolinand
clathrinco
pit
endocytosi
virion
ultim
travel
lysosom
compart
cytosol
releas
target
howev
mlv
gener
releas
cytosol
right
endocytosi
without
reach
lysosom
compart
specif
upon
fusion
event
mlv
particl
host
plasma
membran
virion
core
immedi
deliv
cytoplasm
diamond
farzan
arenavirus
includ
lcmv
lasa
mach
intern
cell
via
unusu
pathway
endocytosi
independ
clathrin
caveolin
kunz
rojek
kunz
thu
action
lysosom
compart
appear
key
factor
specif
effect
iav
vsv
entri
summari
studi
show
antivir
strategi
ifitm
protein
specif
infectioninduc
host
defens
effector
target
vapa
deregul
integr
cholesterol
homeostasi
necessari
order
releas
infecti
virion
particl
observ
also
offer
ifitm
target
therapeut
avenu
combat
viral
infect
yeast
twohybrid
screen
fulllength
cdna
purchas
open
biosystem
lafayett
co
usa
clone
bamhiecori
site
vector
clontech
laboratori
mountain
view
ca
usa
bait
saccharomyc
cerevisia
strain
transform
vector
yeast
express
subject
libraryscal
transform
human
leukocyt
matchmak
cdna
librari
fuse
domain
vector
clontech
laboratori
util
libraryscal
screen
accord
matchmak
twohybrid
system
instruct
clontech
laboratori
transfect
vapa
osbp
vapa
cdna
purchas
open
biosystem
pcr
clone
ecoribamhi
site
lentivector
mammalian
express
system
system
bioscienc
mountain
view
ca
usa
puromycinresist
cell
infect
lentiviru
pseudotyp
machupo
viru
glycoprotein
machgp
carri
vapa
vapaflag
machgp
use
instead
vesicular
stomat
viru
glycoprotein
vsvgp
robustli
restrict
vsvgpmediat
entri
brass
et
al
cell
cultur
immunoblot
immunoprecipit
gst
pulldown
cell
maintain
medium
supplement
fetal
bovin
serum
gibco
life
technolog
grand
island
ny
usa
nonessenti
amino
acid
gibco
appropri
antibiot
puromycin
invitrogen
carlsbad
ca
usa
antibiot
use
gener
cell
line
western
blot
wb
coimmunoprecipit
coip
perform
accord
standard
protocol
deplet
vapa
gene
express
sever
shrna
target
vapa
gene
design
clone
ageiecori
site
lentivector
addgen
cambridg
usa
influenza
viru
influenza
viru
strain
manicassami
et
al
obtain
dr
adolfo
mount
sinai
school
medicin
vsvgfp
vsvwt
virus
kindli
provid
dr
sean
whelan
harvard
medic
univers
cell
infect
influenza
vsv
virus
viral
infect
determin
standard
plaqu
assay
gener
defect
mlvegfp
pseudotyp
viru
coat
differ
viral
envelop
cell
cotransfect
pqcxipegfpretrovirusbas
plasmid
clontech
togeth
mlv
gagpol
express
vector
viral
envelop
express
plasmid
previous
describ
brass
et
al
confoc
immunofluoresc
microscopi
coloc
analysi
cholesterol
quantif
cell
fix
pb
contain
formaldehyd
permeabl
triton
block
bsa
stain
indic
antibodi
confoc
microscopi
nikon
eclips
ti
pearson
correl
coeffici
differ
fluoresc
signal
determin
coloc
analysi
total
free
esterifiedcholesterol
measur
use
cholesterol
quantif
kit
sigmaaldrich
st
loui
standard
protocol
use
sampl
prepar
transmiss
electron
microscopi
tem
immunoelectron
microscopi
electron
microscopi
experi
carri
uscnorri
cell
tissu
imag
core
within
vision
research
center
procedur
found
articl
onlin
http
